We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+452.52%
AUM
$617B
AUM Growth
-$21.7B
Cap. Flow
-$32.7B
Cap. Flow %
-5.31%
Top 10 Hldgs %
14.52%
Holding
11,616
New
1,319
Increased
4,145
Reduced
4,502
Closed
1,184

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.87B
2
AAPL icon
Apple
AAPL
+$1.41B
3
MSFT icon
Microsoft
MSFT
+$1.16B
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.03B
5
LUV icon
Southwest Airlines
LUV
+$727M

Sector Composition

Rank Sector Weight
1 Technology 17.52%
2 Financials 9.54%
3 Healthcare 6.68%
4 Industrials 6.61%
5 Consumer Discretionary 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUKZ icon
5051
Range Nuclear Renaissance Index ETF
NUKZ
$813M
$1.76M ﹤0.01%
27,706
+16,575
+149% +$1.12M
NVRI icon
5052
CALL
Enviri
NVRI
$567M
$1.76M ﹤0.01%
+98,100
New +$1.46M
SBIO icon
5053
ALPS Medical Breakthroughs ETF
SBIO
$212M
$1.75M ﹤0.01%
34,194
+581
+2% +$26.9K
MVIS icon
5054
Microvision
MVIS
$48.3M
$1.75M ﹤0.01%
140,964
+68,952
+96% +$1.1M
HYEM icon
5055
VanEck Emerging Markets High Yield Bond ETF
HYEM
$528M
$1.75M ﹤0.01%
87,999
+17,537
+25% +$350K
BNY
5056
DELISTED
BlackRock New York Municipal Income Trust
BNY
$1.75M ﹤0.01%
172,565
+76,195
+79% +$777K
CXM icon
5057
Sprinklr
CXM
$1.62B
$1.75M ﹤0.01%
224,771
-1,256,494
-85% -$9.56M
FXF icon
5058
Invesco CurrencyShares Swiss Franc Trust
FXF
$397M
$1.75M ﹤0.01%
15,649
+4,086
+35% +$452K
AUTL
5059
Autolus Therapeutics
AUTL
$559M
$1.75M ﹤0.01%
877,100
+466,438
+114% +$717K
AFL icon
5060
PUT
Aflac
AFL
$60.7B
$1.74M ﹤0.01%
15,800
KURE icon
5061
KraneShares MSCI All China Health Care Index ETF
KURE
$106M
$1.74M ﹤0.01%
102,219
+85,487
+511% +$1.63M
GDYN icon
5062
Grid Dynamics Holdings
GDYN
$631M
$1.74M ﹤0.01%
192,802
-179,665
-48% -$1.56M
GSL icon
5063
Global Ship Lease
GSL
$1.51B
$1.74M ﹤0.01%
49,544
-1,824
-4% -$59.3K
FDMT icon
5064
4D Molecular Therapeutics
FDMT
$590M
$1.73M ﹤0.01%
231,292
+136,392
+144% +$1.38M
BRR
5065
ProCap Financial Inc
BRR
$149M
$1.73M ﹤0.01%
490,387
+460,007
+1,514% +$3.67M
VERI icon
5066
CALL
Veritone
VERI
$112M
$1.73M ﹤0.01%
372,000
-372,760
-50% -$2M
CENTA icon
5067
Central Garden & Pet Co Class A
CENTA
$2.41B
$1.73M ﹤0.01%
59,238
-177,545
-75% -$5.13M
ISPY icon
5068
ProShares S&P 500 High Income ETF
ISPY
$1.28B
$1.72M ﹤0.01%
37,756
+22,318
+145% +$1.01M
ACCO icon
5069
Acco Brands
ACCO
$401M
$1.72M ﹤0.01%
461,868
-32,906
-7% -$122K
IRWD icon
5070
Ironwood Pharmaceuticals
IRWD
$668M
$1.72M ﹤0.01%
510,543
-301,121
-37% -$782K
AAT
5071
American Assets Trust
AAT
$1.42B
$1.72M ﹤0.01%
90,881
-164,944
-64% -$3.18M
QCRH icon
5072
QCR Holdings
QCRH
$1.75B
$1.72M ﹤0.01%
20,626
-29,896
-59% -$2.35M
PAYX icon
5073
CALL
Paychex
PAYX
$43.7B
$1.72M ﹤0.01%
15,300
-8,471
-36% -$991K
BGY icon
5074
BlackRock Enhanced International Dividend Trust
BGY
$533M
$1.71M ﹤0.01%
291,465
-74,493
-20% -$430K
SNBR
5075
DELISTED
Sleep Number
SNBR
$1.71M ﹤0.01%
202,431
+90,264
+80% +$571K

Similar funds

UBS Group's Q4 2025 Portfolio in Review

As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.

  • UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
  • UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
  • UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
  • UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
  • UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
  • UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.